Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PEGylated insulin lispro compounds

PEGylated insulin lispro compounds

US Patent 9050371 · Granted Jun 9, 2015

Estimated economic value: $431,207,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Laser diode and method for manufacturing the same2025
Use of anti-PD-1 antibody in combination with famitinib in preparation of drug f2025
Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use2025
Human IL-4R binding antibody, antigen binding fragment thereof, and medical use 2024
Fusion proteins2024
LAG-3 antibody, antigen-binding fragment thereof, and pharmaceutical application2024
Use of combination of anti-PD-1 antibody and VEGFR inhibitor in preparation of d2024
Method for digitizing bone marrow smear2023
PD-L1 antibody, antigen-binding fragment thereof and medical application thereof2023
Interleukin 15 protein complex and use thereof2023
B7-H3 antibody, antigen-binding fragment thereof and medical use thereof2023
Anti-CD40 antibody, antigen binding fragment thereof and medical use thereof2022